Skip to main content

April 1, 2023

Critical Path Institute identifies utility of Goal Attainment Scaling in rare diseases

The Critical Path Institute published a peer-reviewed paper discussing the different approaches to evaluating the clinical benefits of treatments for rare diseases with heterogeneous symptoms and impacts. The publication outlined the potential utility of GAS in rare disease clinical trials.

Contact Us

Local with a global impact

Based in Nova Scotia, our culture reflects an East Coast Canadian ethos rooted in hard work and collegiality.

With over a decade of experience partnering with multinational sponsors on cutting-edge patient-centric research, the impact of our work is global.

Follow us for more: